Moreover, ATP13A2 mutations were also reported in neuronal ceroid lipofuscinosis (NCL)9, amyotrophic lateral sclerosis (ALS)10, and hereditary spastic paraplegia (HSP)11. Here, ATP13A2 is linked to hereditary spastic paraplegia.